Literature DB >> 6768075

High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin.

N Bjørndal, M Bjerre, J Gerlach, P Kristjansen, G Magelund, I H Oestrich, J Waehrens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6768075     DOI： 10.1007/bf00427590

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  28 in total

1.  Recognition and management of drug-induced extra-pyramidal reactions and "paradoxical" behavioural reactions in psychiatry.

Authors:  G J SARWER-FONER
Journal:  Can Med Assoc J       Date:  1960-08-13       Impact factor: 8.262

2.  Adequate individualized dosages (AID) in perspective.

Authors:  J C Maerz
Journal:  Proc R Soc Med       Date:  1976

3.  Prolactin responses to neuroleptics in normal and schizophrenic subjects.

Authors:  P H Gruen; E J Sachar; G Langer; N Altman; M Leifer; A Frantz; F S Halpern
Journal:  Arch Gen Psychiatry       Date:  1978-01

4.  [One years experience with high doses of Flupenthixol-decanoate 10 per cent (Lu 1705)].

Authors:  K Bjerke; A Faurbye; L Kirk
Journal:  Nord Psykiatr Tidsskr       Date:  1972

5.  Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients.

Authors:  S H Curry; J H Marshall
Journal:  Life Sci       Date:  1968-01-01       Impact factor: 5.037

6.  Peroral and parenteral administration of long-acting neuroleptics: a double-blind study of penfluridol compared to flupenthixol decanoate in the treatment of schizophrenia.

Authors:  J Gerlach; P Kramp; P Kristjansen; B Lauritsen; K Lühdorf; I Munkvad
Journal:  Acta Psychiatr Scand       Date:  1975-08       Impact factor: 6.392

7.  Very high dosage vs standard dosage fluphenazine in schizophrenia. A double-blind study of nonchronic treatment-refractory patients.

Authors:  F Quitkin; A Rifkin; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1975-10

Review 8.  Tardive dyskinesia.

Authors:  J Gerlach
Journal:  Dan Med Bull       Date:  1979-08

9.  Rapid treatment of acute psychosis.

Authors:  W H Anderson; J C Kuehnle; D M Catanzano
Journal:  Am J Psychiatry       Date:  1976-09       Impact factor: 18.112

10.  Dopamine, acetylcholine, and GABA effects in acute dystonia in primates.

Authors:  D E Casey; J Gerlach; E Christensson
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
View more
  13 in total

1.  Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients.

Authors:  R Rimón; I Averbuch; P Rozick; L Fijman-Danilovich; T Kara; H Dasberg; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

2.  Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.

Authors:  M Markianos; G Sakellariou; E Bistolaki
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 3.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

4.  Serum concentrations of the isomers of clopenthixol and a metabolite in patients given cis(Z)-clopenthixol decanoate in viscoleo.

Authors:  T Aaes-Jørgensen; L Kirk; E Petersen; P Danneskiold-Samsøe; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

5.  Antiemetic effect of haloperidol in the dog as related to plasma level and dose.

Authors:  C J Niemegeers; J J Heykants; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 6.  The use of carbamazepine in the treatment of schizophrenic and schizoaffective psychoses: a review.

Authors:  C Simhandl; K Meszaros
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

7.  Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patients.

Authors:  M A Moulin; J P Davy; D Debruyne; J C Andersson; M C Bigot; R Camsonne; E Poilpré
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Serum concentrations of cis(Z)-flupentixol and prolactin in chronic schizophrenic patients treated with flupentixol and cis(Z)-flupentixol decanoate.

Authors:  A Jørgensen; J Andersen; N Bjørndal; S J Dencker; L Lundin; U Malm
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Haloperidol plasma levels and clinical response in paranoid schizophrenics.

Authors:  P Linkowski; P Hubain; R von Frenckell; J Mendlewicz
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

Review 10.  Pharmacokinetics of haloperidol.

Authors:  J S Froemming; Y W Lam; M W Jann; C M Davis
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.